ORAL CAVITY CARCINOMA
Clinical trials for ORAL CAVITY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ORAL CAVITY CARCINOMA trials appear
Sign up with your email to follow new studies for ORAL CAVITY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy duo takes on rare cancers in Largest-Ever trial
Disease control OngoingThis study tested a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 different rare tumor types. The goal was to see if these drugs could shrink tumors and help control the cancer. The trial is no longer recruiting, and results are bein…
Matched conditions: ORAL CAVITY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:46 UTC
-
HPV vaccine under the microscope: 10-Year Follow-Up reveals hidden insights
Knowledge-focused OngoingThis study follows over 8,600 women in Costa Rica who received the HPV vaccine (types 16 and 18) and compares them to unvaccinated women. Researchers want to see how long the vaccine protects against cervical cancer and whether it might lead to more lesions from other HPV types. …
Matched conditions: ORAL CAVITY CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:47 UTC